U.S. markets close in 4 hours 53 minutes

Medpace Holdings, Inc. (MEDP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
186.87-4.16 (-2.18%)
As of 11:06AM EDT. Market open.
Sign in to post a message.
  • G
    George
    Up 500% in just the past 5 years! Not too shabby 😊 Keep it going
  • G
    George
    Up, Up and Away …… Looking Good!
  • D
    David
    Medp provides critical phase 1 through four clinical trials which should be in high demand from drug companies around the world. I am long the stock yet do not understand why this message board and others have so few comments about this companies growth prospects in helping drug companies obtain FDA approval for new drugs that can benefit society. I noticed 77% institutional ownership and a 60% gain over last 52 weeks And would think this company services should be in high demand over the next 3 to 5 years, any thoughts?
    Bullish
  • D
    Don
    The following piece outlines what the writer expects in the future for MEDP. "What Are Analysts Saying About Medpace Holdings, Inc.’s Long Term Outlook?" Very encouraging !!
  • S
    Susan
    New business was up 36.4%, y/y net revenues up 28.6%, hiring growth forecast because of new business and expected growth of 11-15 %, adjusted net income $95.5 million over 2018. Sounds good to me. Just bought another 1k. GLTA
  • M
    Mr.
    Anybody know why it’s down 9% today?
  • B
    Barry
    People reacting to the 2019 EPS guidance that is below consensus. But first of all, it's initial guidance which means it's conservative. How conservative? 2019 revenue guidance is for 11-14% growth. But the book:bill ratio is...wait for it...1.28. In other words, their new order growth is 28% but their revenue growth expectation is only 10-14%. Yeah, right. Meanwhile their cash flow margins are 30%. Another case of the Wall Street analysts being way out in front of the company. Stock will be on sale, but only briefly as the smart money sniffs out the management sandbagging.
  • B
    Billboard1909
    IBD says MEDP is close to a buy point @ $64.00 to start the next leg up
  • G
    George
    Can you imagine how far MEDP will drop whenever they Miss their earnings estimates!!
  • D
    Don
    The ER was good. The forecast was respectable. But it's more than that. This is a company who is contributing to humanity. They are ranked highly in their field and will continue to be profitable.
  • D
    Dave
    Total Debt (mrq) 223.66M
    P/E 52.23
  • S
    Susan
    Good buying opportunity. Forecasting $783-807 for 2019 is not bad. They are probably understating just to be sure. Will surprise to the up-side.
  • p
    p h
    Beat and raised guidance
  • B
    Basking Ridge Doc
    Maybe a little correction after having gone up a lot lately?
    Bullish
  • C
    Cohnstein
    Just a tad overbought now?
  • G
    George
    Conference call tomorrow morning should be very interesting. A lot of wall street analysts will be listening now. All ABOARD!
  • N
    Night Hawk
    Bought shares when it was down 4% today..... Nice recovery
  • G
    George
    Yet another Great quarter and End of Year report! Numbers blew away
    Wall Street once more. The analysts will continue playing catch-up here. Go Long, Stay Strong!
    Bullish
  • G
    George
    Once again, the analysts will be chasing this stock with their upgrades. It’s 7/23 and the highest projected 12 mo. Target is only 95. Currently MEDP is sitting at $111/ share. Go Long, Stay Strong!